Cargando…
Limited Expression of Cytochrome P450 17α-Hydroxylase/17,20-Lyase in Prostate Cancer Cell Lines
PURPOSE: Cytochrome P450 17α-hydroxylase/17,20-lyase (CYP17A1) is a key enzyme in the androgen biosynthesis pathway. CYP17A1 has been focused on because of the promising results of a potent CYP17A1 inhibitor in the treatment of castration-resistant prostate cancer (CRPC). A hypothesis that intratumo...
Autores principales: | Jeong, Chang Wook, Yoon, Cheol Yong, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok-Soo, Lee, Sang Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Urological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3151639/ https://www.ncbi.nlm.nih.gov/pubmed/21860772 http://dx.doi.org/10.4111/kju.2011.52.7.494 |
Ejemplares similares
-
New insights on hyperglycemia in 17-hydroxylase/17,20-lyase deficiency
por: Xu, Lingling, et al.
Publicado: (2022) -
Two cases of 17α-hydroxylase/17,20-lyase deficiency caused by the CYP17A1 mutation
por: Lee, Hae In, et al.
Publicado: (2021) -
17α-hydroxylase/17,20-lyase deficiency in congenital adrenal hyperplasia: A case report
por: Xu, Simiao, et al.
Publicado: (2017) -
17α-Hydroxylase/17,20-Lyase Deficiency in 46,XY: Our Experience and Review of Literature
por: Maheshwari, Madhur, et al.
Publicado: (2022) -
Dexamethasone application for in vitro fertilisation in non-classic 17-hydroxylase/17,20-lyase-deficient women
por: Yang, Xiu-Li, et al.
Publicado: (2022)